Leuprolide
Lupron • Eligard • Leuprorelin
Mechanism
Luteinizing hormone-releasing hormone (LHRH) agonist that initially stimulates then suppresses gonadotropin release. Used to treat hormone-sensitive cancers and conditions.
Half-Life
3-4 hours
Administration
Technical Protocol
Leuprolide: Comprehensive Research Guide
Overview
Leuprolide (Lupron, Eligard) is a synthetic nonapeptide analog of gonadotropin-releasing hormone (GnRH). It acts as a luteinizing hormone-releasing hormone (LHRH) agonist and is used to treat hormone-sensitive cancers, endometriosis, and precocious puberty.
Mechanism of Action
Hormone Suppression
- Initial Stimulation: Initially stimulates LH and FSH release
- **Downregulation': After initial surge, suppresses gonadotropin release
- **Hormone Reduction': Reduces testosterone and estrogen levels
- **Tumor Control': Controls hormone-sensitive tumors
Therapeutic Effects
- **Prostate Cancer': Suppresses testosterone in prostate cancer
- **Endometriosis': Suppresses estrogen in endometriosis
- **Precocious Puberty': Delays puberty in children
- **Uterine Fibroids': Reduces fibroid size
Research Applications
Medical Applications
- **Prostate Cancer': Treatment of advanced prostate cancer
- **Endometriosis': Treatment of endometriosis
- **Precocious Puberty': Treatment of precocious puberty
- **Uterine Fibroids': Treatment of uterine fibroids
Research
- **Hormone Research': Research into hormone regulation
- **Cancer Research': Research into hormone-sensitive cancers
Dosage
- **Prostate Cancer': 7.5 mg monthly or 22.5 mg every 3 months
- **Endometriosis': 3.75 mg monthly
- **Precocious Puberty': Dose varies by weight
- **Administration': Subcutaneous or intramuscular injection
Side Effects
- **Hot Flashes': Common hot flashes
- **Libido': Decreased libido
- **Fatigue': Possible fatigue
- **Mood Changes': Possible mood changes
- **Bone Loss': Long-term bone density loss
Storage
- **Temperature': 2-8°C (refrigerated)
- **Light': Protect from light
- **Stability': Relatively stable
This information is for research and educational purposes only. Leuprolide is a prescription medication.
Peer-Reviewed Citations
Leuprolide acetate in the treatment of prostate cancer
Sharifi R, et al. • Urology (2001)
Access ResearchFrequently Asked Questions
What is Leuprolide?
An LHRH agonist used to treat prostate cancer, endometriosis, and precocious puberty. Initially stimulates then suppresses hormone production.
How does Leuprolide work?
Luteinizing hormone-releasing hormone (LHRH) agonist that initially stimulates then suppresses gonadotropin release. Used to treat hormone-sensitive cancers and conditions.
What is the typical dosage of Leuprolide in research?
The typical research dosage of Leuprolide is 3.75-7.5 mg (range: 1-7.5 mg). Common administration routes include Subcutaneous, Intramuscular.
How should Leuprolide be stored?
Store at 2-8°C, protect from light
Related Hormonal Peptides
Ipamorelin
A potent and selective growth hormone secretagogue that stimulates growth hormone release.
hormonalCJC-1295 (No DAC)
A modified version of GHRH 1-29, designed to stimulate growth hormone release.
hormonalTesamorelin
The most potent GHRH analog for visceral fat reduction.
hormonalKisspeptin-10
A key regulator of the reproductive axis.